| | Transsulcal approach supported by navigation-guided neurophysiological monitoring for resection of paracentral cavernomasReceived 8 November 2007; received in revised form 30 August 2008; accepted 4 September 2008. Abstract ObjectivesThe aim of the study is to evaluate tools that can improve surgical precision and minimize surgical trauma for removal of cavernomas in the paracentral area. Moreover, the surgical strategies for the treatment of symptomatic epilepsy in cavernoma patients are discussed. Patients and methodsBetween June 2000 and July 2007, 17 patients suffering from paracentral cavernoma underwent surgery via a transsulcal approach with the aid of neuronavigation, functional mapping and neurophysiological intraoperative monitoring. To optimize outcome for procedures in the paracentral area, the hemosiderin-stained tissue was removed entirely except for a small proportion on the side of precentral gyrus. ResultsAll cavernomas and their adjacent sulci could be precisely located with the aid of ultrasonography-assisted neuronavigation. By combining preoperative fMRI and intraoperative neurophysiological monitoring, including SEP, MEP and cortical mapping, the motor cortex could be defined in all cases. Thus damage to the primary motor area could be avoided during resection of cavernomas. All the lesions located in the paracentral area were removed completely via transsulcal microsurgical approach without neurological deficits. No significant seizures were induced during surgery. ConclusionsThe successful excision of these lesions was effected by the following four key factors: (1) the precise location of the lesion supported by intraoperative neuronavigation; (2) the preservation of the eloquent area with the aid of functional mapping; (3) a minimally invasive transsulcal microsurgical approach; and (4) the entire removal of cavernoma and hemosiderin-stained tissue. 1. Introduction  Cavernomas in the paracentral area have been one of the most challenging cerebrovascular disorders in neurosurgery due to the risks associated with their surgical removal. For example, some deeply located or small subcortical cavernomas can be difficult to be located and excised because of their location in or underneath the eloquent area. Dissection during the procedure may cause immediate minor cortical injury and subsequent clinical damage in motor and/or sensory function. Epileptic seizures constitute the most frequent clinical presenting symptom of these patients due to the epileptogenic potential of blood breakdown products within the perilesional area [1]. Moreover cavernomas bear a risk of intra- and perilesional hemorrhage, which may lead to severe neurological deficit and permanent disability [1]. Dealing with these lesions, neurosurgeons must consider the risk of surgery and balance it with the benefits of improving the patient’s clinical condition and the possibility of preventing future problems. In this study, we described our surgical approach for cavernomas in the paracentral area. The use of a transsulcal approach guided by frameless ultrasound-assisted neuronavigation, functional mapping and neurophysiological intraoperative monitoring to minimize morbidity are evaluated. The technical details of this minimally invasive approach are discussed. 2. Patients and methods  2.1. Patients and nature of lesions Between June 2000 and July 2007, 17 patients harboring a paracentral cavernoma underwent surgery via transsulcal approach with the aid of frameless neuronavigation and neurophysiological intraoperative monitoring. 6 patients were male and 11 were female, and the patients ranged in age from 17 to 65 years (mean ± S.D., 41.24 ± 13.52 years). There are eight cavernomas located in the right and nine in the left hemisphere. The size of lesions varied between 8 mm up to 45 mm in diameter (mean ± S.D., 23.06 ± 10.29 mm). The depth of the cavernomas ranged from 5 mm up to 40 mm. The space-occupying lesions were located in the frontal lobe rostral to the precentral gyrus in 2 subjects, in the precentral gyrus in 3 subjects, and in the postcentral gyrus in 5 subjects. Seven lesions extended into more than one cerebral gyrus. Three subjects had multiple lesions. In these 3 subjects, only the paracentral lesions were removed surgically, and other supratentorial or infratentorial lesions were left untreated in this study. In one patient the cavernoma was associated with a venous malformation. Four patients with cavernomas suffered from acute hematomas. All patients had various symptoms including headache, hemiparesis, hemihypesthesia or epileptic seizures. Eight patients suffered from seizures. Of these eight patients, 3 patients with simple partial seizures, 2 patients with complex partial seizures, and 3 patients had a history of generalized seizures. All patients had at least two seizures per year despite adequate antiepileptic therapy. In these patients, EEG revealed an epileptic focus with a topographic relation to the cavernoma. In cases of multiple cavernomas, Video-EEG-Monitoring was used to identify the seizure focus. The details of clinical symptoms in all patients are summarized in Table 1. | | |  | Case number | Age (yr)/sex | Presenting symptoms | Size (mm) | Side | Location | Follow-up (month) | Outcome at follow up |  |
|---|
 | 1 | 65/F | Seizures, right sided hemiparesis | 30 | L | Frontal + precentral | 12 | No seizures, hemiparesis improved |  |  | 2 | 46/F | Seizures, minor paresis of the right leg | 18 | L | Postcentral | 13 | No seizures, no deficits |  |  | 3 | 29/M | Left sided central facial palsy paresthesia of the left arm and face | 26 | R | Precentral | 15 | Symptom-free, no deficits |  |  | 4 | 60/F | Seizures, right sided hemiparesis and slight aphasia | 32 | L | Frontal + precentral | 28 | No seizures, hemiparesis unchanged, no new deficit |  |  | 5 | 27/F | Headache, paresthesia of the right arm | 8 | L | Postcentral | 31 | Symptom-free, no deficits |  |  | 6 | 32/M | Headache, hemihypesthesia, problems with speaking | 25 | L | Precentral + postcentral (multiple) | 30 | Symptom improved, hemihypesthesia, no new deficits |  |  | 7 | 17/F | Transient paresis of the left arm, left sided hemihypesthesia, seizures | 34 | R | Precentral + postcentral | 30 | No seizures, symptom-free, no deficits |  |  | 8 | 30/F | Seizures, transient left sided hemiparesis | 25 | R | Postcentral | 2 | One seizure within first 2 weeks after operation, and then symptom-free, no deficits |  |  | 9 | 29/F | Seizures, hemihypesthesia of the left arm, hemiparesis | 10 | R | Postcentral (cavernoma + VM) | 35 | No seizures, no deficits |  |  | 10 | 39/M | Asymptomatic concerning cavernoma | 10 | R | Postcentral | 19 | No deficits |  |  | 11 | 38/M | Dysaethesia of the right hand and face, dysarthria | 12 | L | Precentral | 19 | Symptom-free, no deficits |  |  | 12 | 55/F | Hemorrhage twice, headache | 12 | L | Frontal | 31 | Headache, no deficits |  |  | 13 | 46/F | Left sided hemiparesis | 30 | R | Frontal + precentral (multiple) | 34 | Leg paresis improved, no deficits |  |  | 14 | 40/M | Right sided hemiparesis, aphasia | 30 | L | Precentral + postcentral | 11 | Symptom-free, no deficits |  |  | 15 | 35/F | Seizures, headache | 45 | R | Frontal + precentral (multiple) | 40 | No seizures, symptom-free, no deficits |  |  | 16 | 54/F | Seizures | 25 | R | Frontal | 1 | No seizures, symptom-free, no deficits |  |  | 17 | 57/M | Seizures | 20 | L | Precentral | 81 | No seizures, symptom-free, no deficits |  | | | |
2.2. Image guidance system and image-guided sonography The detail technical features of the VectorVision2 (BrainLAB, Heimstetten, Germany) neuronavigation system have been reported previously [2], [3], [4]. Following MRI or CT data acquisition and presurgical planning, the processed patient data were transferred onto the neuronavigation system. The patient registration was performed using standard fiducials. During the period between June 2000 and March 2005, a conventional intraoperative ultrasound (Aplio, phased array probe, 4.8–8.5 MHz, Toshiba, Tokyo, Japan) was used in 9 subjects to aid neuronavigation, and from March 2005 to July 2007, a new image-guided sonography was used in the remaining 8 patients. The technological integration of navigated ultrasound with our novel neuronavigation platform has been described previously [5], [6]. Briefly, a high-end ultrasound device (IGSonic, phased array probe, 5–7.5 MHz, BrainLAB) is directly integrated into the VectorVision2 neuronavigation system by a navigation software (VV Cranial, BrainLAB). The navigation system displays the preoperative MRIs as well as the intraoperative ultrasound scan on a touch screen monitor. For a fusion and contrast of the presurgical MRI/CT images versus in-life ultrasound images during surgery, the presurgical image shown in gray-scale was overlaid with real time B-mode ultrasound images shown in green color. Landmarking of the vascular anatomy using color and power duplex techniques was performed in some patients, the procedure was described previously [7]. 2.3. Functional mapping and neurophysiological intraoperative monitoring We have applied various techniques of functional mapping and neurophysiological intraoperative monitoring (IOM) over the past decade in an effort to ameliorate the technological support of our surgery in eloquent areas. We updated our equipment within the course of our study continuously from somatosensory evoked potential (SEP), motor evoked potential (MEP) to cortical mapping and preoperative functional MRI (fMRI), recently. IOM of SEP, MEP and cortical mapping for the localization of primary motor cortex (M1) were conducted under general anesthesia. fMRI was performed in the five most recent cases of 17 patients. 2.3.1. Evoked potentials (SEP and MEP) Evoked potentials were measured in 16 patients for intraoperative functional monitoring and M1 localization. To localize the central sulcus, a four-contact linear subdural strip electrodes (AD-TECH Co., WI, USA) was placed on the cortex (Fig. 1, Fig. 2). A series of recordings were made from the cortical surface by moving the electrode to find and verify the localization of somatosensory cortex by using a referential montage with median or tibial nerve stimulation, until the highest amplitude of N20/P25 or P40/N50 and shortest latency was recorded. The central sulcus is localized by means of SEP phase reversal. An Endeavor CR IOM system (Viasys Healthcare, Nicolet Biomedical, WI, USA) was used for all examinations. MEP was continuously recorded to monitor motor function. Muscle action potentials were recorded from the forearm flexor, thenar and quadriceps muscle, contralateral to the side of stimulation. Neurophysiological monitoring was performed through out surgery (Fig. 3Q–S). Baseline readings were obtained prior to skin incision and for intradural surgery after opening of the dura mater. Critical SEP and MEP changes were defined as decreases in amplitude of more than 50% of baseline values or increases in latency of more than 10% of baseline values. 2.3.3. Intraoperative electrocorticography (ECoG) monitoring In 8 patients with symptomatic seizures, subdural electrode strips (AD-TECH Co., WI, USA) were placed on the paracentral cortex to define the epileptogenic areas. A portable EEG machine (ACME, Los Angeles, CA, USA) was used for intraoperative ECoG monitoring (Fig. 2K). Intraoperative ECoG recordings were reviewed by neurologists for continuous spikes, bursts, or recruiting discharges and to determine whether these patterns were spatially coincident with the lesion. Typically, the epileptic foci are confined to the lesion and the surrounding brain tissue. And when the lesions were removed, repeated ECoG checked out the residual spikes, which helped us to identify the residual epileptic foci. 2.4. Surgical procedure After induction of general anesthesia, patients were positioned supine with mild head extension and rotation to the contralateral side of the lesion. The image-guided excision of the cavernoma was performed in three steps. First, the skin incision and the osteoplastic craniotomy were made according to the exact location and the size of the cavernoma after transcranial visualization of the cavernoma and adjacent sulcus by navigation. Usually a linear incision of 5–6 cm was adequate for a small lesion less than 1.5 cm (Fig. 4M). As for some big lesion a flap was performed to adapt the whole lesion. Secondly, after the craniotomy had been completed, the central sulcus and precentral gyrus or postcentral gyrus, as well as the cavernoma were identified with the aid of the navigation system again (Fig. 1H–M). Then the functional area was confirmed by neurophysiological test. As for the patients with epilepsy, subdural electrode strips were placed on the brain cortex to define the epileptogenic areas as well as to compare with the pre-operation assessment. Thirdly, the sulcus opening site was chosen to give the shortest and safest corridor to remove the lesion and minimize the potential injury of neural function (Fig. 4A–I). To verify the actual location and adjust the trajectory of dissection toward the lesion during surgery, the navigation guide was applied throughout surgery, and revised by the intraoperative ultrasound (Fig. 1, Fig. 3, Fig. 5). The malformation was removed, including the surrounding hemosiderin-stained gliotic tissue on the side of the frontal lobe and the postcentral gyrus, to eliminate its potential epileptogenic effect, but keep a small proportion on the side of precentral gyrus (Fig. 3W). This maneuver was undertaken with special precautions to avoid injury to adjacent functional structures. Eventually, following closure of dura, cranioplasty and wound closure were performed by standard neurosurgical techniques. In each patient, an early postoperative CT scan was obtained to rule out any local hemorrhage. 2.5. Opening of the sulcus In all 17 patients, transsulcal approaches (transcentral sulcus in 6, transprecentral sulcus in 6 and transpostcentral sulcus in 5 patients) were used to reach the lesions. The initial incision was made based on the individual shape of the sulcus and the function of surrounding cortex. Usually hemosiderin-stained tissues on the surface were the first signs of cavernoma would suggest the entrance and direction of dissection (Fig. 4D). If the sulcus above the lesion was tight due to brain edema or adhesion of the arachnoid membranes, a relatively normal part of the sulcus was dissected first along the cortical artery, followed by extending the space to the lesion. On the brain surface, the subarachnoid membrane was cut with a minimal tension on the left by applying gentle retraction onto a cottonoid sponge placed on the adjacent tissue. Subsequently, a sharp incision of the superficial arachnoidal layer and underlying arachnoidal bands was made under high magnification. In opening of the sulcus, microscissors were used as much as possible to avoid cortical injuries due to retraction and coagulation by bipolar forceps [8], [9]. After the pial surface covering the lesion was reached, the lesions were then excised under bipolar low-current coagulation. Great care was taken to maintain the patency of the sites identified as M1 by fMRI, SEP phase reversal or cortical mapping. A self-retaining retractor placed over a cottonoid strip was used in the deep area but its application was limited to a short duration as appropriate. Larger and deeper lesions required longer arachnoidal incisions to avoid any traction at the extremities of arachnoidal incision and minimize compression on the exposed cortical surface within the sulcus. 3. Results  In all subjects, the cavernoma and adjacent sulcus could be precisely located with the aid of ultrasonography-assisted neuronavigation technology. As shown in Fig. 1, Fig. 3, Fig. 5, cavernomas manifested as structures with high echogenicity on ultrasound images. The direct comparison of corresponding MRI and US images allowed a detection of brain shift in 4/8 cases operated with the aid of the integrated US-navigation (Fig. 5F). The location of M1 was detected by preoperative fMRI in 5 patients. In these cases, the preoperative and postoperative deficits corresponded to the activated area next to the lesion that was identified by fMRI images. Intraoperative localization of the central sulcus based on the SEP recording of the inversion of a postcentral negative and a precentral positive peak, the N20–P25 phase reversal, could be identified in 12 of 16 patients. In three cases, cortical mapping was performed, and was able to characterize the function of this area. Intraoperative MEP monitoring suggested that there was no secondary damage to the motor area. The transsulcal approach to the lesions was successfully applied and complete excision of the cavernomas was achieved in all 17 patients, including 10 deeper located and 5 small (about 1 cm) subcortical lesions. In 4 patients, sulci over the cavernoma accompanied by hemorrhage were edematous and arachnoid membranes were adhering with each other. In these 4 patients, the relatively normal sulcus corresponding to the face area was opened at first, followed by dissection to the lesion located under the hand area. In one patient with cavernoma associated venous anomaly, extra care was taken to leave the venous anomaly intact. No significant seizures were induced during surgery in any patient. In the 8 patients with concomitant epilepsy, the intraoperative ECoG findings suggested the characteristic coincident continuous spiking around the lesions with or without focal slow wave activity. When the lesions were removed, repeated ECoG monitored the residual spikes which were used to guide the careful removal of residual epileptic foci. 6/8 patients were free of seizure and free of auras after surgery (ILAE 1), and they were followed beyond 12 months and up to 81 months. The other two patients were lost to long-term follow-up. After surgery, none of the patients experienced postoperative motor function deterioration, and 5 patients had obvious postoperative improvement in motor function (Table 1), and there were no obvious postoperative neurological damage and no morbidity. 4. Discussion  Various successful surgical approaches for cavernomas have been reported during the past two decades [1], [10], [11], [12]. However, the precise localization of subcortical lesions in the paracentral area while maintaining essential functions in adjacent areas still remain a challenge even for experienced neurosurgeons. In this report, cavernomas in the paracentral area were removed with no morbidity. The successful excision of these lesions was effected by the following four key factors: First, the precise location of the lesion; secondly, the precise evaluation of the functional area; thirdly, the choice of a minimal invasive surgical approach; and fourthly, the entire removal of cavernoma and careful removal of hemosiderin-stained tissue. 4.1. Ultrasonography-assisted image-guided neuronavigation Precise identification of anatomical landmarks and avoidance of vital structures are crucial during presurgical planning and during surgery, this is evidenced by the reduced morbidity following the application of navigation system [13], [14]. Because most image guidance relies on preoperative digital images, intraoperative loss of CSF and the effect of cortical displacement can affect the accuracy of the navigation system [3], [4], [15], [16], [17]. Supplementing preoperative digital images with intraoperative ultrasound offered one solution to overcome this problem of brain shift during surgery. A simple image overlay [6], [18] or a display of sonographic and corresponding tomographic scans side by side [19] in the system for image-guided ultrasound can identify any tissue shift in a two-dimensional plane and provide an estimate of brain shift. This is helpful for surgeon to adjust to the altered brain shape during surgery. Moreover, integration of the ultrasound into the navigation system with MRI or CT images obtained a priori help to better interpret the intraoperative sonographic data [5], [7], [20]. Intraoperative CT/MRI are other navigation modalities that can help to adapt surgery to the brain shift and are currently being applied [21], [22], [23], [24]. Compared to ultrasound images, CT and MRI images possess higher resolution. However, these technologies are costly and require cumbersome procedures. They are rigid and difficult to adopt for continuous real-time imaging during surgery. In comparison, ultrasound performs true real-time imaging, and it is time- and cost-effective and flexible, can be relatively easily made to address various emergences in surgery [6], [7], [20], [25]. 4.2. Evaluation of functional mapping with combined methods, localization of the primary motor cortex Surgical removal of brain lesions located within or near the motor cortex frequently results in postoperative deterioration of motor function. fMRI and intraoperative neurophysiological monitoring have been used to help identify and preserve the eloquent area during surgical resection of brain tumors. When appropriately applied, these techniques may identify M1 and are helpful to improve neurosurgical outcomes in certain situations [26], [27], [28], [29], [30]. However, it has been well recognized that using these techniques alone was sometimes not sufficient for the accurate localization of M1 and may result in postoperative motor deficits [31], [32], [33]. For example, SEP is a simple and useful technique, and its principle is based on the fact that a somatosensory potential is recorded from the sensory cortex and that its mirror image is recorded from the motor cortex [34]. But its utility is limited in the context of large central and postcentral tumors. Shinoura et al. [35] found even though phase reversal was successfully detected, SEP was not completely reliable in localizing the M1 in the context of an underlying lesion, because reorganization of brain function could produce a shift in the SEP. Still other studies have suggested that intraoperative cortical mapping may have low sensitivity for the detection of motor function in the area besides the lesion [36], with the risk of induction of epilepsy and postepileptic paresis. All these data suggest that the use of SEP or brain mapping alone was insufficient and a combination of multiple methods should be applied for the accurate localization of M1 rather than use of one method alone [35], [37]. In this report, lesions located in the paracentral area were removed completely without further neurological deficits by using continuous functional monitoring. A combination of preoperative fMRI and IOM, including SEP, MEP and cortical mapping, has been used to prevent compromise of M1 during resection of cavernomas. In our practice, besides the updating of the new techniques, we try to gather more information about the motor functional area from various methods. All these data were analyzed and compared with each other. For example, SEP phase reversal allows intraoperative localization of the central sulcus but yields no functional information [37], and in recent years we use direct stimulation of the motor cortex to ensure intraoperative identification of motor areas. In most of the cases, the data of fMRI, SEP and intraoperative cortical mapping are highly concordant and complementary. However, the functional areas detected by these techniques can be different due to functional reorganization of the M1 [38], [39], [40]. When this happened, or SEP/cortical mapping provided equivocal information on the cortical representation of motor territories, we usually assume that the location of M1 detected by fMRI was correct, and performed surgery based on that information. This was based on the evidences that fMRI using alone was more reliable than SEP or brain mapping for the detection of M1 in proximity to a lesion [35]. 4.3. Transsulcal approach The surface of the human brain cortex comprises several convoluted folds, the gyri, separated by slanted spaces, the sulci, and displays significant individual variation in morphology. As anticipated, transcortical and remote approaches always involve traumatic injury to surrounding brain tissue, thus, the transsulcus approach is the best way to be considered to minimize collateral damage, as working through these natural tunnels leads to safer surgery [41], [42], [43]. Generally the transsulcal approach should be considered according to the location of lesions and the spatial relationship between lesions and functional areas adjacent to the lesions. If the facial area is close to the lesion, dissection should be started from the facial area to the hand area to avoid retraction to cortex in the hand area. Besides the precise location of the lesion and avoidance of functional areas for determining the entrance and direction of dissection, it is especially important to perform basic microsurgical techniques [8]. It is of critical importance to take advantage of the natural sulci of the brain and to continue the furthest possible dissection in the natural pathways. Usually, the veins integrated in the arachnoid of the sulcus, are freed by sharp dissection with the least coagulation, so that even small veins running along and then down into the deep sulcus can be preserved (Fig. 4C and H). A microsiphon over the cotton on the superficial cortex is suitable for transient and minimal brain retraction. A feasible part of the sulcus, with relatively less edema and adhesion between arachnoid membranes, should be located and opened in the first place. Then, the working space in the sulcus can be extended deeply and widely to the lesions. Self-retractors, if necessary, could be applied on the postcentral gyrus, not on the precentral gyrus only during the manipulation at the deep part of the sulcus, and they should be loosened frequently. In summary, as a minimally invasive technique, transsulcal microsurgical approach based on anatomic and functional information allow surgeons to reach and remove lesions deep in the paracentral area with minimal brain tissue loss. In this series, this approach was successfully conducted without any neurological damage in all patients. 4.4. Treatment of concomitant epilepsy associated with cavernoma Epileptic seizures are the most frequent concomitant symptom of supratentorial cavernomas (40–70%) [44], [45]. In this series, 8/17 patients had clinical symptom of seizures. The exact mechanisms of epilepsy associated with cavernoma are complex with no available consensus. There is no definite evidence that a space-occupying mass effect account for the high epileptogenicity of this vascular malformation [46]; rather, the microhemorrhages leading to a hemosiderin fringe and hemin deposits in the tissue surrounding the cavernoma are believed to be responsible for cavernoma associated epilepsy. Iron can induce epilepsy in different ways; in addition, reactive glial proliferation and altered synaptic activity may be epileptogenic [47]. The optimal surgical management of symptomatic epileptic seizures caused by cavernomas is still a matter of debate [48]. Most studies are in agreement that early operation, which reduces the preoperative duration of epilepsy, is associated with a better outcome [44], [49], [50], [51]. But whether microsurgical lesionectomy, including the removal of only the cavernoma alone, or a more extensive resection is necessary to achieve this aim remains controversial [47]. Based on the understanding of the main cause of epileptogenesis of cavernomas is pathologic changes in the adjacent brain tissue, many authors believe that a satisfactory therapeutic outcome requires complete elimination of the epileptogenic foci, with an extended lesionectomy including perilesional tissue if the ECoG reveals focal epileptic activity or a hemosiderin fringe is detected [44], [45], [52]. And the determination of surgical resection boundaries cannot rely merely on imaging techniques, but that functional examinations such as the EEG or MEG should be applied. However, some other studies failed to find any substantial evidence that the additional excision of the hemosiderin-stained tissue around the cavernoma provided better results than merely resection of the cavernoma [53], [54], and more invasive and costly studies to find and remove the epileptogenic cerebral parenchyma seem justified only after lesionectomy fails [55]. Because of these contradictory reports, neurosurgeons often are in a dilemma when dealing with cavernomas: on the one hand, they use a minimal surgical approach to avoid unnecessary damage to brain tissue; on the other hand, resections should be extensive enough to remove the total of epileptogenic tissue. In our opinion, in contrast to other structural lesions such as dysembryoplastic neuroepithelial tumors or gangliogliomas, the vascular malformation itself is usually not responsible for the epilepsy in patients with cavernomas [47]. The complete removal not only of the cavernoma itself but also of the surrounding hemosiderin-stained brain tissue improves long-term outcome of seizures in symptomatic epilepsy, which has been confirmed by many studies [56]. But considering the risk/benefit of procedures in the paracentral area, we often remove the hemosiderin-stained tissue or surrounding epileptogenic brain tissue delineated by new electrophysiological investigation techniques on the side of frontal lobe or the postcentral gyrus, and keep a small proportion on the side of precentral gyrus. On the other hand, evaluating lesions in the vicinity of the central region with regard to symptomatic epilepsy, ECoG might be useful to confirm and monitor cortical seizure activity. 5. Conclusions  The improved visualization of cavernoma and adjacent structures, lesion remnants, and the enhanced intra- and perilesional vasculature are main advantages of ultrasonography-assisted neuronavigation in surgery. This is most obvious for surgery to remove paracentral cavernomas. It allows a tailored craniotomy and optimized dural incision with the shortest and safest corridor to the lesion through the sulcus. A combination of preoperative fMRI and neurophysiological intraoperative monitoring, including SEP, MEP and cortical mapping, has been successfully used to avoid damaging of the primary motor area during resection of cavernomas. Transsulcal microsurgical approach based on anatomic and functional information allow surgeons to reach and remove lesions deep in the paracentral area with minimal brain tissue loss. To optimize outcome for procedures in the paracentral area, the hemosiderin-stained tissue should be removed entirely except for a small proportion on the side of precentral gyrus. References  [1]. [1]Bertalanffy H, Benes L, Miyazawa T, Alberti O, Siegel AM, Sure U. Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev. 2002;25(1–2):1–53. MEDLINE |
CrossRef
[2]. [2]Gumprecht HK, Widenka DC, Lumenta CB. BrainLab VectorVision neuronavigation system: technology and clinical experiences in 131 cases. Neurosurgery. 1999;44(1):97–104.
CrossRef
[3]. [3]Sure U, Alberti O, Petermeyer M, Becker R, Bertalanffy H. Advanced image-guided skull base surgery. Surg Neurol. 2000;53(6):563–572. Abstract | Full Text |
Full-Text PDF (1112 KB)
|
CrossRef
[4]. [4]Sure U, Benes L, Riegel T, Schulte DM, Bertalanffy H. Image fusion for skull base neuronavigation. Technical note. Neurol Med Chir (Tokyo). 2002;42(10):458–461. MEDLINE |
CrossRef
[5]. [5]Sure U, Thiemann I, Schmidt R, Bozinov O, Benes L, Bertalanffy H. A novel one-platform image-guided-system with precalibrated ultrasound probe. In: Klug N, Nyary I, Fedorcsák I editor. 55 Jahrestagung der Deutschen Gesellschaft für Neurochirurgie. Köln: Verlag, Videel, Niebüll; 2004;p. 106. [6]. [6]Tirakotai W, Miller D, Heinze S, Benes L, Bertalanffy H, Sure U. A novel platform for image-guided ultrasound. Neurosurgery. 2006;58(4):710–718.
CrossRef
[7]. [7]Sure U, Benes L, Bozinov O, Woydt M, Tirakotai W, Bertalanffy H. Intraoperative landmarking of vascular anatomy by integration of duplex and Doppler ultrasonography in image-guided surgery. Technical note. Surg Neurol. 2005;63(2):133–141. Abstract | Full Text |
Full-Text PDF (643 KB)
|
CrossRef
[8]. [8]Mikuni N, Hashimoto N. A minimally invasive transsulcal approach to the paracentral inner lesion. Minim Invasive Neurosurg. 2006;49(5):291–295. MEDLINE |
CrossRef
[9]. [9]Hashimoto N. Microsurgery for cerebral arteriovenous malformations: a dissection technique and its theoretical implications. Neurosurgery. 2001;48(6):1278–1281.
CrossRef
[10]. [10]Grunert P, Charalampaki K, Kassem M, Boecher-Schwarz H, Filippi R, Grunert P. Frame-based and frameless stereotaxy in the localization of cavernous angiomas. Neurosurg Rev. 2003;26(1):53–61. MEDLINE |
CrossRef
[11]. [11]Mathiesen T, Edner G, Kihlstrom L. Deep and brainstem cavernomas: a consecutive 8-year series. J Neurosurg. 2003;99(1):31–37. MEDLINE |
CrossRef
[12]. [12]Huang YC, Tseng CK, Chang CN, Wei KC, Liao CC, Hsu PW. LINAC radiosurgery for intracranial cavernous malformation: 10-year experience. Clin Neurol Neurosurg. 2006;108(8):750–756. Abstract | Full Text |
Full-Text PDF (513 KB)
|
CrossRef
[13]. [13]Willems PW, van der Sprenkel JW, Tulleken CA, Viergever MA, Taphoorn MJ. Neuronavigation and surgery of intracerebral tumours. J Neurol. 2006;253(9):1123–1136. MEDLINE |
CrossRef
[14]. [14]Spetzger U, Laborde G, Gilsbach JM. Frameless neuronavigation in modern neurosurgery. Minim Invasive Neurosurg. 1995;38(4):163–166. MEDLINE |
CrossRef
[15]. [15]Roberts DW, Hartov A, Kennedy FE, Miga MI, Paulsen KD. Intraoperative brain shift and deformation: a quantitative analysis of cortical displacement in 28 cases. Neurosurgery. 1998;43(4):749–758.
CrossRef
[16]. [16]Hartkens T, Hill DL, Castellano-Smith AD, Hawkes DJ, Maurer CR, Martin AJ, et al. Measurement and analysis of brain deformation during neurosurgery. IEEE Trans Med Imaging. 2003;22(1):82–92. MEDLINE |
CrossRef
[17]. [17]Hastreiter P, Rezk-Salama C, Soza G, Bauer M, Greiner G, Fahlbusch R, et al. Strategies for brain shift evaluation. Med Image Anal. 2004;8(4):447–464. Abstract | Full Text |
Full-Text PDF (1951 KB)
|
CrossRef
[18]. [18]Haberland N, Ebmeier K, Hliscs R, Grnewald JP, Silbermann J, Steenbeck J, et al. Neuronavigation in surgery of intracranial and spinal tumors. J Cancer Res Clin Oncol. 2000;126(9):529–541. MEDLINE |
CrossRef
[19]. [19]Gronningsaeter A, Kleven A, Ommedal S, Aarseth TE, Lie T, Lindseth F, et al. SonoWand, an ultrasound-based neuronavigation system. Neurosurgery. 2000;47(6):1373–1379.
CrossRef
[20]. [20]Miller D, Heinze S, Tirakotai W, Bozinov O, Surucu O, Benes L, et al. Is the image guidance of ultrasonography beneficial for neurosurgical routine?. Surg Neurol. 2007;67(6):579–587. Abstract | Full Text |
Full-Text PDF (601 KB)
|
CrossRef
[21]. [21]Black PM, Moriarty T, Alexander E, Stieg P, Woodard EJ, Gleason PL, et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery. 1997;41(4):831–842.
CrossRef
[22]. [22]Steinmeier R, Fahlbusch R, Ganslandt O, Nimsky C, Buchfelder M, Kaus M, et al. Intraoperative magnetic resonance imaging with the magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report. Neurosurgery. 1998;43(4):739–747.
CrossRef
[23]. [23]Matula C, Rossler K, Reddy M, Schindler E, Koos WT. Intraoperative computed tomography guided neuronavigation: concepts, efficiency, and work flow. Comput Aided Surg. 1998;3(4):174–182. MEDLINE |
CrossRef
[24]. [24]Bernays RL. Intraoperative imaging in neurosurgery, MRI, CT, ultrasound. Introduction. Acta Neurochir Suppl. 2003;85:1–3. MEDLINE [25]. [25]Unsgaard G, Ommedal S, Muller T, Gronningsaeter A, Nagelhus Hernes TA. Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection. Neurosurgery. 2002;50(4):804–812.
CrossRef
[26]. [26]Jack CR, Thompson RM, Butts RK, Sharbrough FW, Kelly PJ, Hanson DP, et al. Sensory motor cortex: correlation of presurgical mapping with functional MR imaging and invasive cortical mapping. Radiology. 1994;190(1):85–92. MEDLINE [27]. [27]Krings T, Reinges MH, Erberich S, Kemeny S, Rohde V, Spetzger U, et al. Functional MRI for presurgical planning: problems, artefacts, and solution strategies. J Neurol Neurosurg Psychiatry. 2001;70(6):749–760. MEDLINE |
CrossRef
[28]. [28]Lehericy S, Duffau H, Cornu P, Capelle L, Pidoux B, Carpentier A, et al. Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg. 2000;92(4):589–598. MEDLINE |
CrossRef
[29]. [29]Yousry TA, Schmid UD, Jassoy AG, Schmidt D, Eisner WE, Reulen HJ, et al. Topography of the cortical motor hand area: prospective study with functional MR imaging and direct motor mapping at surgery. Radiology. 1995;195(1):23–29. MEDLINE [30]. [30]Reithmeier T, Krammer M, Gumprecht H, Gerstner W, Lumenta CB. Neuronavigation combined with electrophysiological monitoring for surgery of lesions in eloquent brain areas in 42 cases: a retrospective comparison of the neurological outcome and the quality of resection with a control group with similar lesions. Minim Invasive Neurosurg. 2003;46(2):65–71. MEDLINE |
CrossRef
[31]. [31]Babu KS, Chandy MJ. Reliability of somatosensory evoked potentials in intraoperative localization of the central sulcus in patients with perirolandic mass lesions. Br J Neurosurg. 1997;11(5):411–417. MEDLINE |
CrossRef
[32]. [32]Wildforster U, Falk A, Harders A. Operative approach due to results of functional magnetic resonance imaging in central brain tumors. Comput Aided Surg. 1998;3(4):162–165. MEDLINE |
CrossRef
[33]. [33]Romstock J, Fahlbusch R, Ganslandt O, Nimsky C, Strauss C. Localisation of the sensorimotor cortex during surgery for brain tumours: feasibility and waveform patterns of somatosensory evoked potentials. J Neurol Neurosurg Psychiatry. 2002;72(2):221–229. MEDLINE |
CrossRef
[34]. [34]Wood CC, Spencer DD, Allison T, McCarthy G, Williamson PD, Goff WR. Localization of human sensorimotor cortex during surgery by cortical surface recording of somatosensory evoked potentials. J Neurosurg. 1988;68(1):99–111. MEDLINE |
CrossRef
[35]. [35]Shinoura N, Yamada R, Suzuki Y, Kodama T, Sekiguchi K, Takahashi M, et al. Functional magnetic resonance imaging is more reliable than somatosensory evoked potential or mapping for the detection of the primary motor cortex in proximity to a tumor. Stereotact Funct Neurosurg. 2007;85(2–3):99–105. MEDLINE |
CrossRef
[36]. [36]Shinoura N, Yamada R, Kodama T, Suzuki Y, Takahashi M, Yagi K. Intraoperative cortical mapping has low sensitivity for the detection of motor function in proximity to a tumor in the primary motor area. Stereotact Funct Neurosurg. 2005;83(4):135–141. MEDLINE |
CrossRef
[37]. [37]Kombos T, Suess O, Funk T, Kern BC, Brock M. Intra-operative mapping of the motor cortex during surgery in and around the motor cortex. Acta Neurochir (Wien). 2000;142(3):263–268. MEDLINE |
CrossRef
[38]. [38]Duffau H, Denvil D, Capelle L. Long term reshaping of language, sensory, and motor maps after glioma resection: a new parameter to integrate in the surgical strategy. J Neurol Neurosurg Psychiatry. 2002;72(4):511–516. MEDLINE [39]. [39]Fandino J, Kollias SS, Wieser HG, Valavanis A, Yonekawa Y. Intraoperative validation of functional magnetic resonance imaging and cortical reorganization patterns in patients with brain tumors involving the primary motor cortex. J Neurosurg. 1999;91(2):238–250. MEDLINE |
CrossRef
[40]. [40]Krings T, Topper R, Willmes K, Reinges MH, Gilsbach JM, Thron A. Activation in primary and secondary motor areas in patients with CNS neoplasms and weakness. Neurology. 2002;58(3):381–390. MEDLINE [41]. [41]Yasargil MG. Microneurosurgery. Volume 3B. Surgical concerns. New York: Thieme; 1988;. [42]. [42]Jabre A, Patel A. Transsulcal microsurgical approach for subcortical small brain lesions: technical note. Surg Neurol. 2006;65(3):312–313. Abstract | Full Text |
Full-Text PDF (216 KB)
|
CrossRef
[43]. [43]Garcia SR, Pulido P, Kusak E. Transfissural or transsulcal approach versus combined stereotactic microsurgical approach. Acta Neurochir Suppl (Wien). 1991;52:22–25. MEDLINE [44]. [44]Cohen DS, Zubay GP, Goodman RR. Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg. 1995;83(2):237–242. MEDLINE |
CrossRef
[45]. [45]Stefan H, Hammen T. Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand. 2004;110(6):393–397. MEDLINE |
CrossRef
[46]. [46]Robinson JR, Awad IA, Magdinec M, Paranandi L. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993;32(5):730–735. [47]. [47]Kraemer DL, Awad IA. Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia. 1994;35(Suppl. 6):S30–43.
CrossRef
[48]. [48]Shih YH, Pan DH. Management of supratentorial cavernous malformations: craniotomy versus gammaknife radiosurgery. Clin Neurol Neurosurg. 2005;107(2):108–112. Abstract | Full Text |
Full-Text PDF (62 KB)
|
CrossRef
[49]. [49]Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E. Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg. 1997;99(3):179–183. Abstract |
Full-Text PDF (437 KB)
|
CrossRef
[50]. [50]Ojemann RG, Ogilvy CS. Microsurgical treatment of supratentorial cavernous malformations. Neurosurg Clin N Am. 1999;10(3):433–440. MEDLINE [51]. [51]Baumann CR, Acciarri N, Bertalanffy H, Devinsky O, Elger CE, Lo Russo G, et al. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia. 2007;48(3):559–563. MEDLINE |
CrossRef
[52]. [52]Cosgrove GR. Occult vascular malformations and seizures. Neurosurg Clin N Am. 1999;10(3):527–535. MEDLINE [53]. [53]Casazza M, Broggi G, Franzini A, Avanzini G, Spreafico R, Bracchi M, et al. Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery. 1996;39(1):26–32.
CrossRef
[54]. [54]Zevgaridis D, van Velthoven V, Ebeling U, Reulen HJ. Seizure control following surgery in supratentorial cavernous malformations: a retrospective study in 77 patients. Acta Neurochir (Wien). 1996;138(6):672–677. MEDLINE |
CrossRef
[55]. [55]Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G. Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci. 2006;26(6):390–394. MEDLINE |
CrossRef
[56]. [56]Baumann CR, Schuknecht B, Lo Russo G, Cossu M, Citterio A, Andermann F, et al. Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia. 2006;47(3):563–566. MEDLINE |
CrossRef
a Department of Neurosurgery, Philipps-University, Baldingerstrasse, 35033 Marburg, Germany b Department of Neurosurgery, Renji Hospital, Shanghai Jiaotong University, 200127 Shanghai, PR China c Department of Neurology, Philipps-University, Rudolf-Bultmann-Straße 8, 35039 Marburg, Germany d Department of Neurosurgery, University Clinic Zuerich, CH-8091 Zuerich, Switzerland Corresponding author at: Department of Neurosurgery, Renji Hospital, Shanghai Jiaotong University, 200127 Shanghai, PR China. Tel.: +86 13311713837.
PII: S0303-8467(08)00301-6 doi:10.1016/j.clineuro.2008.09.025 © 2008 Elsevier B.V. All rights reserved. | |
|